Atlas Trials

Personnalized Immunotherapy in Patients With Stage III Non-small Cell Lung Cancer

Clinical trial NCT07759492 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07759492
Sponsor
Intergroupe Francophone de Cancerologie Thoracique
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Non-small Cell Lung Cancer Stage III Unresectable
Start date
2026-11-01
Primary completion
2030-11-01
Enrollment
177

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.